IDEAS home Printed from https://ideas.repec.org/a/spr/rrorus/v12y2022i2d10.1134_s2079970522020174.html
   My bibliography  Save this article

Location of the Largest Pharmaceutical Companies in Russia: Contribution to Regional Divergence or Convergence?

Author

Listed:
  • O. V. Kuznetsova

    (Plekhanov Russian University of Economics
    Federal Research Center “Computer Science and Control,” Russian Academy of Sciences)

  • R. O. Bobrovsky

    (Plekhanov Russian University of Economics
    Moscow State University)

Abstract

— The objective of the article is to identify factors for the location of pharmaceutical enterprises in Russian regions, including from the viewpoint of assessing the possible contribution of the pharmaceutical industry to the reduction of territorial disproportions in the level of economic development. The pharmaceutical production location factors is analyzed based on a generalization of foreign studies on the topic and a database compiled by the authors on the manufacturing enterprises of more than 50 largest pharmaceutical companies in Russia (taking into account the construction time and large-scale modernization of enterprises belonging to Russian or foreign owners). It is concluded that Russia experiences the same factors of pharmaceutical enterprises’ location as abroad: the importance of historically established centers of production is characteristic, including in the eastern regions of the country (due to the reduced role of the transport factor for the industry); preference is often given to expanding capacities of already existing enterprises, instead of construction of new ones; new factories appear on the basis of established pharmaceutical research centers and/or with focus on markets of the largest urban agglomerations and/or in special economic zones and industrial parks. When building new enterprises, investors can seek both to participate in pharmaceutical clusters and save on production costs, including wages, by building factories in areas not saturated in industries. Foreign investment mainly reach only to the western regions of the country due to their capacious sales market and proximity to the countries of origin of companies, which are predominantly European. As a result of numerous factors, the impact of development of pharmaceutical production on territorial disproportions is ambiguous.

Suggested Citation

  • O. V. Kuznetsova & R. O. Bobrovsky, 2022. "Location of the Largest Pharmaceutical Companies in Russia: Contribution to Regional Divergence or Convergence?," Regional Research of Russia, Springer, vol. 12(2), pages 124-132, June.
    • Handle: RePEc:spr:rrorus:v:12:y:2022:i:2:d:10.1134_s2079970522020174
    DOI: 10.1134/S2079970522020174
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1134/S2079970522020174
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1134/S2079970522020174?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Su Li & Antonio Angelino & Haitao Yin & Francesca Spigarelli, 2017. "Determinants of FDI Localization in China: A County-Level Analysis for the Pharmaceutical Industry," IJERPH, MDPI, vol. 14(9), pages 1-20, August.
    2. Francesca Bignami & Pauline Mattsson & Jarno Hoekman, 2020. "The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry," Industry and Innovation, Taylor & Francis Journals, vol. 27(5), pages 513-537, May.
    3. Vigdis Boasson & Alan MacPherson & Hyun-Han Shin, 2005. "Firm Value and Geographic Competitive Advantage: Evidence from the U.S. Pharmaceutical Industry," The Journal of Business, University of Chicago Press, vol. 78(6), pages 2465-2495, November.
    4. Robert Kaiser, 2003. "Multi-level Science Policy and Regional Innovation: The Case of the Munich Cluster for Pharmaceutical Biotechnology," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 841-857, October.
    5. Chris Egeraat & Declan Curran, 2013. "Spatial Concentration in the Irish Pharmaceutical Industry: The Role of Spatial Planning and Agglomeration Economies," Tijdschrift voor Economische en Sociale Geografie, Royal Dutch Geographical Society KNAG, vol. 104(3), pages 338-358, July.
    6. Pelin Demirel & Mariana Mazzucato, 2010. "The Evolution of Firm Growth Dynamics in the US Pharmaceutical Industry," Regional Studies, Taylor & Francis Journals, vol. 44(8), pages 1053-1066.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Peng Wang & Xiaoyan Lin & Dajun Dai, 2017. "Spatiotemporal Agglomeration of Real-Estate Industry in Guangzhou, China," Sustainability, MDPI, vol. 9(8), pages 1-15, August.
    2. Ferretti, Marco & Guerini, Massimiliano & Panetti, Eva & Parmentola, Adele, 2022. "The partner next door? The effect of micro-geographical proximity on intra-cluster inter-organizational relationships," Technovation, Elsevier, vol. 111(C).
    3. Mohd Shahidan Shaari & Muhamad Huzaifah Asbullah & Noorazeela Zainol Abidin & Zulkefly Abdul Karim & Benjamin Nangle, 2023. "Determinants of Foreign Direct Investment in ASEAN+3 Countries: The Role of Environmental Degradation," IJERPH, MDPI, vol. 20(3), pages 1-14, January.
    4. O’Leary Eoin, 2018. "Planning Ireland to 2040: How to address our economic development policy weaknesses," Administration, Sciendo, vol. 66(1), pages 89-105, February.
    5. Cécile Crespy & Jean-Alain Héraud & Beth Perry, 2007. "Regierungsführung auf mehreren Ebenen, Regionen und Wissenschaft in Frankreich: zwischen Wettbewerb und Gleichheit [Multi-level governance, regions and science in France: between competition and eq," Post-Print hal-00514676, HAL.
    6. Yinhao Wu & Shumin Yu & Xiangdong Duan, 2021. "The Impact of Environmental Regulation on the Location of Pollution-Intensive Industries in China under Agglomeration Effect," IJERPH, MDPI, vol. 18(8), pages 1-14, April.
    7. Michaela Trippl & Joshua von Gabain & Franz Tödtling, 2006. "Policy agents as catalysts of knowledge links in the biotechnology sector," SRE-Disc sre-disc-2006_01, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    8. Marek Csabay & Zuzana Vincúrová & Milan Stoch & Beáta Stehlíková, 2021. "Enterprise ownership patterns in the least developed districts of Slovakia," Equilibrium. Quarterly Journal of Economics and Economic Policy, Institute of Economic Research, vol. 16(4), pages 807-838, December.
    9. Brache, Jose & Felzensztein, Christian, 2019. "Geographical co-location on Chilean SME's export performance," Journal of Business Research, Elsevier, vol. 105(C), pages 310-321.
    10. Jean Dubé & Cédric Brunelle, 2014. "Dots to dots: a general methodology to build local indicators using spatial micro-data," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 53(1), pages 245-272, August.
    11. Hans Löfsten & Anders Isaksson & Heikki Rannikko, 2023. "Entrepreneurial networks, geographical proximity, and their relationship to firm growth: a study of 241 small high-tech firms," The Journal of Technology Transfer, Springer, vol. 48(6), pages 2280-2306, December.
    12. Philip Cooke, 2010. "Global Bioregions: Knowledge Domains, Capabilities and Innovation System Networks," Chapters, in: Riccardo Viale & Henry Etzkowitz (ed.), The Capitalization of Knowledge, chapter 5, Edward Elgar Publishing.
    13. Kaiser, Robert & Prange, Heiko, 2004. "The reconfiguration of National Innovation Systems--the example of German biotechnology," Research Policy, Elsevier, vol. 33(3), pages 395-408, April.
    14. Shihong Zeng & Ya Zhou, 2021. "Foreign Direct Investment’s Impact on China’s Economic Growth, Technological Innovation and Pollution," IJERPH, MDPI, vol. 18(6), pages 1-24, March.
    15. Giovanni Abramo & Francesca Apponi & Ciriaco Andrea D’Angelo, 2024. "The moderating role of the territorial research infrastructure on the geographic proximity effect in research collaborations: a regional-based view," Scientometrics, Springer;Akadémiai Kiadó, vol. 129(6), pages 3149-3168, June.
    16. Jinho Choi & Nina Shin & Yong Sik Chang, 2021. "Strategic Investment Decisions for Emerging Technology Fields in the Health Care Sector Based on M&A Analysis," Sustainability, MDPI, vol. 13(7), pages 1-20, March.
    17. Bas Karreman & Martijn J. Burger & Fred van Eenennaam, 2019. "Revealed competition between cluster organizations: An exploratory analysis of the European life sciences sector," Environment and Planning A, , vol. 51(3), pages 705-723, May.
    18. Lee, Chang-Yang, 2018. "Geographical clustering and firm growth: Differential growth performance among clustered firms," Research Policy, Elsevier, vol. 47(6), pages 1173-1184.
    19. Franz Tödtling & Michaela Trippl & Joshua von Gabain, 2006. "Clusterentwicklung und -politik im Biotechnologiesektor Wien im Kontext internationaler Erfahrungen," SRE-Disc sre-disc-2006_02, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    20. Manuel A. Espitia Escuer & Lucia I. Garcia Cebrian & Antonio Munoz Porcar, 2011. "Las Caracteristicas De Las Empresas Como Factores Determinantes En Su Localizacion," Revista Internacional Administracion & Finanzas, The Institute for Business and Finance Research, vol. 4(3), pages 99-111.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:rrorus:v:12:y:2022:i:2:d:10.1134_s2079970522020174. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.